The tests are designated a Class I recall, which is used for devices that may cause serious injuries or death, the agency said. They were distributed to customers without FDA authorization.
North American Diagnostics failed to provide sufficient data showing the test is accurate, the agency said.
The company is requesting that customers and distributors identify and destroy any of the unused kits, the FDA said.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
